The complex molecule extracted from genes of living organisms by utilizing advanced DNA technologies is collectively known as biologics.
The complex molecule extracted from genes of living organisms by utilizing advanced DNA technologies is collectively known as biologics. Biologics are advanced drugs that are utilized in the treatment of rheumatoid arthritis, cancer, and other diseases. These biologics comprise large molecules like recombinant proteins, monoclonal antibodies, and also they ensure patient safety as they are utilized in the treatment of many life-threatening diseases. Such biologics are actively incorporated in the innovation of new medicines as well as the enhancement of existing ones. Biologics safety testing is vital for avoiding the inadvertent inclusion of anonymous entities in the drug manufacturing system.
One of the primary reasons for the growth of the global biologics safety testing market is the rapid proliferation of the biologics and biosimilars market globally. However, the growing biopharmaceutical outsourcing is likely to provide ample thrust to the growth of the market. The fast-growing pharmaceutical sector along with heavy research and development activities by prominent key players in the life sciences sector will further boost the demand for biology safety testing. The growing prevalence of targeted disease globally is significantly fuelling the production of advanced biologics. There is an intense competition among leaders to innovate advanced drugs to improve the manufacturing processes like cost efficiency and productivity. The surging companies are adopting high-end manufacturing practices including thorough biological testing at a different level of the production cycle, thereby promoting the growth of the global market. However, the growing initiatives from the government to encourage biology safety testing products are expected to promulgate the adoption of biological safety testing vigorously.
According to the report, global demand for biologics safety testing market was valued at approximately USD 3.16 billion in 2018, and is expected to generate revenue of around USD 6.79 billion by end of 2025, growing at a CAGR of around 11.6% between 2019 and 2025.
The global biologics safety testing market can be segmented into test type, application, product, and region.
By test type, the market can be segmented into residual DNA detection test, bioburden test, mycoplasma test, sterility test, endotoxin test, and virus safety test.
By application, the market can be segmented into stem cell research, tissue-related product testing, cellular & gene therapy, blood & blood-related product testing, vaccine & therapeutics development, and others.
By product, the market can be segmented into services, instruments, and reagents & kits.
North America accounts for the largest share in the global biologics safety testing market due to the growing investments in biotechnology from prominent market leaders and government authorities in the region. However, the growth in the development and innovation of new biologics drugs and vaccines will boost the growth of the regional market.
Get Sample of this Research Report for more Insights – https://www.zionmarketresearch.com/sample/biologics-safety-testing-market
Some of the significant players in the global biologics safety testing market are SGS S.A., Wuxi Apptec, Toxikon Corporation, Eurofins Scientific Se, Lonza Group Ltd., Pace Analytical Services Inc., Biomérieux Sa, Genscript, Thermo Fisher Scientific Inc., and Charles River Laboratories International, Inc. To cite, Charles River Laboratories, Inc. (US) in 2021 partnered with JADE Biomedical to widen their biological testing capabilities globally.
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us –
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com